10-102836639-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000102.4(CYP17A1):c.297+426G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.375 in 199,818 control chromosomes in the GnomAD database, including 14,476 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.39   (  11490   hom.,  cov: 30) 
 Exomes 𝑓:  0.34   (  2986   hom.  ) 
Consequence
 CYP17A1
NM_000102.4 intron
NM_000102.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.136  
Publications
31 publications found 
Genes affected
 CYP17A1  (HGNC:2593):  (cytochrome P450 family 17 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. It has both 17alpha-hydroxylase and 17,20-lyase activities and is a key enzyme in the steroidogenic pathway that produces progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens. Mutations in this gene are associated with isolated steroid-17 alpha-hydroxylase deficiency, 17-alpha-hydroxylase/17,20-lyase deficiency, pseudohermaphroditism, and adrenal hyperplasia. [provided by RefSeq, Jul 2008] 
CYP17A1 Gene-Disease associations (from GenCC):
- congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- 46,XY disorder of sex development due to isolated 17,20-lyase deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.543  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.386  AC: 58556AN: 151618Hom.:  11480  Cov.: 30 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
58556
AN: 
151618
Hom.: 
Cov.: 
30
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.339  AC: 16289AN: 48082Hom.:  2986   AF XY:  0.339  AC XY: 8444AN XY: 24922 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
16289
AN: 
48082
Hom.: 
 AF XY: 
AC XY: 
8444
AN XY: 
24922
show subpopulations 
African (AFR) 
 AF: 
AC: 
473
AN: 
1624
American (AMR) 
 AF: 
AC: 
1386
AN: 
3798
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
356
AN: 
1088
East Asian (EAS) 
 AF: 
AC: 
1374
AN: 
2792
South Asian (SAS) 
 AF: 
AC: 
1787
AN: 
6016
European-Finnish (FIN) 
 AF: 
AC: 
455
AN: 
1436
Middle Eastern (MID) 
 AF: 
AC: 
51
AN: 
164
European-Non Finnish (NFE) 
 AF: 
AC: 
9599
AN: 
28728
Other (OTH) 
 AF: 
AC: 
808
AN: 
2436
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.480 
Heterozygous variant carriers
 0 
 493 
 987 
 1480 
 1974 
 2467 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 154 
 308 
 462 
 616 
 770 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.386  AC: 58609AN: 151736Hom.:  11490  Cov.: 30 AF XY:  0.384  AC XY: 28472AN XY: 74130 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
58609
AN: 
151736
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
28472
AN XY: 
74130
show subpopulations 
African (AFR) 
 AF: 
AC: 
14708
AN: 
41340
American (AMR) 
 AF: 
AC: 
5969
AN: 
15254
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1383
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
2881
AN: 
5140
South Asian (SAS) 
 AF: 
AC: 
1692
AN: 
4810
European-Finnish (FIN) 
 AF: 
AC: 
3743
AN: 
10538
Middle Eastern (MID) 
 AF: 
AC: 
108
AN: 
290
European-Non Finnish (NFE) 
 AF: 
AC: 
27127
AN: 
67880
Other (OTH) 
 AF: 
AC: 
818
AN: 
2102
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1829 
 3658 
 5486 
 7315 
 9144 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 576 
 1152 
 1728 
 2304 
 2880 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1416
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.